Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Comparison of agonist/antagonist versions of a synthetic tracer for human bradykinin B1 receptor imaging using positron emission tomography

Guillaume Amouroux, Zhengxing Zhang, Jinhe Pan, Silvia Jenni, Navjit Hundal-Jabal, Francois Benard and Kuo-Shyan Lin
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 441;
Guillaume Amouroux
1BC Cancer Agency, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhengxing Zhang
1BC Cancer Agency, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinhe Pan
1BC Cancer Agency, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvia Jenni
1BC Cancer Agency, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Navjit Hundal-Jabal
1BC Cancer Agency, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Benard
1BC Cancer Agency, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuo-Shyan Lin
1BC Cancer Agency, Vancouver, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 55 no. supplement 1 441

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 5, 2014.

Copyright & Usage 
© 2014

Author Information

  1. Guillaume Amouroux1,
  2. Zhengxing Zhang1,
  3. Jinhe Pan1,
  4. Silvia Jenni1,
  5. Navjit Hundal-Jabal1,
  6. Francois Benard1 and
  7. Kuo-Shyan Lin1
  1. 1BC Cancer Agency, Vancouver, BC, Canada

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014300
Jan 2015100
Feb 2015100
Apr 2015300
May 2015100
Jun 2015300
Aug 2015600
Sep 20152100
Oct 2015100
Nov 2015200
Jan 2016300
Mar 2016300
May 2016100
Jul 2016200
Aug 2016200
Sep 2016500
Oct 2016100
Nov 2016300
Dec 2016400
Feb 2017800
Mar 2017200
Apr 2017300
May 2017800
Jun 2017400
Jul 2017300
Aug 2017200
Sep 2017200
Oct 2017300
Nov 2017100
Jan 2018200
Feb 2018100
Mar 2018400
Apr 2018300
Jun 2018100
Jul 2018400
Aug 2018100
Oct 2018200
Nov 2018800
Jan 2019200
Feb 2019100
Mar 2019100
May 2019200
Jun 2019200
Jul 2019200
Aug 2019300
Sep 2019300
Oct 2019200
Nov 2019300
Dec 2019300
Jan 2020500
Feb 20201400
Mar 20201600
Apr 20201000
May 2020100
Jun 2020300
Jul 2020200
Aug 20201100
Sep 20201900
Oct 20201100
Nov 20201400
Dec 2020800
Jan 2021200
Feb 2021500
Mar 2021600
Apr 2021400
May 2021600
Jun 2021400
Jul 20211000
Aug 20212100
Sep 2021900
Oct 2021800
Nov 20216800
Dec 20212600
Jan 20224400
Feb 20221400
Mar 2022700
Apr 2022500
May 20222300
Jun 2022700
Jul 2022300
Aug 2022400
Sep 2022300
Oct 2022100
Dec 2022300
Jan 2023400
Feb 2023400
Mar 2023400
Apr 2023100
May 2023300
Jun 2023200
Jul 2023100
Aug 2023400
Sep 2023200
Oct 2023300
Nov 2023400
Dec 2023500
Jan 2024500
Feb 2024100
Mar 2024300
Apr 2024300
May 2024300
Jul 2024400
Aug 20241500
Sep 20241700
Oct 2024400
Nov 2024400
Dec 2024700
Jan 2025300
Feb 2025200
Mar 2025900
Apr 2025700
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of agonist/antagonist versions of a synthetic tracer for human bradykinin B1 receptor imaging using positron emission tomography
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of agonist/antagonist versions of a synthetic tracer for human bradykinin B1 receptor imaging using positron emission tomography
Guillaume Amouroux, Zhengxing Zhang, Jinhe Pan, Silvia Jenni, Navjit Hundal-Jabal, Francois Benard, Kuo-Shyan Lin
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 441;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of agonist/antagonist versions of a synthetic tracer for human bradykinin B1 receptor imaging using positron emission tomography
Guillaume Amouroux, Zhengxing Zhang, Jinhe Pan, Silvia Jenni, Navjit Hundal-Jabal, Francois Benard, Kuo-Shyan Lin
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 441;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Assessment of α4β2 nicotinic acetylcholine receptor (nAChR) availability and neuronal response to rewarding food-cues in human obesity using simultaneous PET-MRI
  • Bridging brain structural/functional connectivity and tau load in PSP: A [18F]PI-2620 PET/MRI study
  • MACROPA highly stable chelator of Radium-223 and functionalization attempts for targeted treatment of cancer
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Peptide-Based Oncology Imaging Probes

  • Development of a novel 18F-labeled NGR peptide via bioorthogonal click chemistry for PET imaging of CD13 receptor expression
  • 18F-BF3-B9858: A promising PET tracer for imaging bradykinin B1 receptor expression in cancer
Show more Peptide-Based Oncology Imaging Probes

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire